Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|December 29, 2000
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancerF J Esteva, L T Soh, F A Holmes, et al.British Journal of Cancer|January 10, 2013
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasY Delpech, C Coutant, L Hsu, et al.NPJ Breast Cancer|January 15, 2020
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancerA Giro-Perafita, L Luo, A Khodadadi-Jamayran, et al.Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Survival among women with triple receptor-negative breast cancer and brain metastasesS Dawood, K Broglio, F J Esteva, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Defining prognosis for women with breast cancer and CNS metastases by HER2 statusS Dawood, K Broglio, F J Esteva, et al.Cancer Chemotherapy and Pharmacology|January 29, 1999
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)Q Dong, S P Johnson, O M Colvin, et al.Oncogene|April 19, 2016
WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastomaJ Wen, J Lee, A Malhotra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerE Rivera, V Valero, L Syrewicz, et al.Pageof 4